| Stage | ASTH | % of rev | MGNI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $973M | 100.00% | $193M | 100.00% | ASTH ×5.04 |
| Gross profit | $104M | 10.70% | $131M | 67.83% | MGNI +57.1pp |
| Operating income | $34M | 3.53% | $31M | 16.19% | MGNI +12.7pp |
| Pre-tax income | $27M | 2.80% | $26M | 13.25% | MGNI +10.5pp |
| Net income | $18M | 1.90% | $19M | 10.04% | MGNI +8.1pp |
| Stage | ASTH | MGNI | Gap · A − B |
|---|---|---|---|
| Revenue | $973M100.00% | $193M100.00% | ASTH ×5.04 |
| Gross profit | 10.70%$104M | 67.83%$131M | MGNI +57.1pp |
| Operating income | 3.53%$34M | 16.19%$31M | MGNI +12.7pp |
| Pre-tax income | 2.80%$27M | 13.25%$26M | MGNI +10.5pp |
| Net income |
| 1.90%$18M |
| 10.04%$19M |
| MGNI +8.1pp |